Ketoralac en es it fr

Ketoralac Brand names, Ketoralac Analogs

Ketoralac Brand Names Mixture

  • No information avaliable

Ketoralac Chemical_Formula


Ketoralac RX_link

Ketoralac fda sheet

Ketoralac FDA

Ketoralac msds (material safety sheet)

Ketoralac Synthesis Reference

No information avaliable

Ketoralac Molecular Weight

285.303 g/mol

Ketoralac Melting Point

184-185 oC

Ketoralac H2O Solubility

No information avaliable

Ketoralac State


Ketoralac LogP


Ketoralac Dosage Forms


Ketoralac Indication

For the extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy. Also for first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Ketoralac Pharmacology

Letrozole is an aromatase inhibitor used in the treatment of breast cancer. Aromatase inhibitors work by inhibiting the action of the enzyme aromatase, which converts androgens into estrogens by a process called aromatization. As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue.

Ketoralac Absorption

Rapidly and completely absorbed. Absorption is not affected by food.

Ketoralac side effects and Toxicity

No information avaliable

Ketoralac Patient Information

No information avaliable

Ketoralac Organisms Affected

Humans and other mammals